Perimeter Medical Imaging AI Inc

Healthcare CA PINK

0.5CAD
0.03(6.38%)

Last update at 2026-03-10T19:59:00Z

Day Range

0.440.50
LowHigh

52 Week Range

0.170.66
LowHigh

Fundamentals

  • Previous Close 0.47
  • Market Cap32.78M
  • Volume311253
  • P/E Ratio3.13
  • Dividend Yield-%
  • EBITDA-14.80327M
  • Revenue TTM1.99M
  • Revenue Per Share TTM0.02
  • Gross Profit TTM 1.58M
  • Diluted EPS TTM0.08

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -13.39393M -18.94420M -9.90611M -16.65177M -7.88597M
Minority interest - - - - -
Net income -13.39393M -18.94420M -9.90611M -16.65177M -7.88597M
Selling general administrative 12.23M 6.12M 10.28M 11.56M 8.96M
Selling and marketing expenses - 4.96M - - -
Gross profit 0.54M -0.35784M 0.10M 0.00504M -
Reconciled depreciation 0.73M 0.61M 0.80M 0.09M 0.05M
Ebit - -22.27167M - - -10.06163M
Ebitda - -21.44201M -9.00031M -16.44763M -7.73583M
Depreciation and amortization - 0.83M - - -
Non operating income net other - - - - -
Operating income -18.70571M -22.27167M -16.12131M -16.05820M -10.06163M
Other operating expenses - 22.82M - - 0.48M
Interest expense 0.03M 0.14M 0.10M 0.11M 0.12M
Tax provision - 0.00000M 0.00000M 0.00000M 0.00000M
Interest income - - - 0.01M 0.00690M
Net interest income 0.27M 0.58M -0.10493M -0.10049M -1.72350M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - 0.00000M - - -
Total revenue 0.85M 0.54M 0.13M 0.01M 0.00000M
Total operating expenses 19.55M 21.91M 16.25M 16.07M 10.06M
Cost of revenue 0.31M 0.90M 0.03M 0.00630M -
Total other income expense net 5.04M 3.33M 6.32M -0.49308M 3.90M
Discontinued operations - - - - -
Net income from continuing ops -13.39393M -14.03599M -9.90611M -16.65177M -7.88597M
Net income applicable to common shares - - - - -7.88597M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 14.33M 27.09M 34.60M 9.98M 13.16M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - 1.48M - - -
Total liab 3.87M 7.10M 8.49M 2.56M 2.40M
Total stockholder equity 10.45M 19.86M 26.11M 7.42M 10.76M
Deferred long term liab - - - - -
Other current liab 0.05M 4.57M 6.04M - 0.52M
Common stock - 107.89M - - 48.50M
Capital stock 90.60M 81.82M 80.84M 62.47M 48.50M
Retained earnings -86.75290M -96.73114M -59.32298M -63.98144M -47.32967M
Other liab - - - - 0.27M
Good will - - - - -
Other assets - - - - -
Cash 6.18M 18.43M 28.44M 4.72M 10.03M
Cash and equivalents - - - - -
Total current liabilities 3.58M 6.91M 8.04M 2.15M 1.82M
Current deferred revenue - 0.05M - - -
Net debt - -18.17991M - - -
Short term debt - 0.07M - - -
Short long term debt - - 0.11M 0.13M 0.05M
Short long term debt total - 0.25M - - -
Other stockholder equity - 10.07M - - 0.18M
Property plant equipment - - - - 0.08M
Total current assets 9.97M 23.18M 31.50M 7.74M 13.07M
Long term investments - - - - -
Net tangible assets - - - - 10.76M
Short term investments - - 0.00000M 0.42M 1.67M
Net receivables 0.39M 3.10M 0.07M - 0.60M
Long term debt - - 0.00965M 0.16M 0.29M
Inventory 0.19M 0.17M 0.04M 0.00649M -
Accounts payable - 2.22M - - 1.21M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - -1.36160M - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.00000M - - - -
Deferred long term asset charges - - - - -
Non current assets total 4.36M 3.90M 3.10M 2.25M 0.09M
Capital lease obligations 0.14M 0.19M 0.21M 0.15M 0.06M
Long term debt total - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments -1.89966M 0.21M -1.74879M -1.44806M 6.33M
Change to liabilities - - 0.00000M -0.90960M -0.16156M
Total cashflows from investing activities - - - - 7.24M
Net borrowings -0.07223M -0.28484M - - -0.14109M
Total cash from financing activities 8.58M 0.32M 40.28M 10.06M 9.84M
Change to operating activities - - - -0.48625M -0.51238M
Net income -13.39393M -18.94420M -9.90611M -16.65177M -7.88597M
Change in cash -8.04086M -20.09923M 26.67M -5.30512M 8.81M
Begin period cash flow 13.98M 38.53M 3.72M 10.03M 1.21M
End period cash flow 6.18M 18.43M 28.44M 4.72M 10.03M
Total cash from operating activities -14.72302M -19.83534M -11.86791M -13.91239M -8.26299M
Issuance of capital stock 8.65M 0.00000M 38.14M 0.00000M 9.41M
Depreciation 0.73M 0.83M 0.80M 0.09M 0.05M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory -0.06258M -0.11623M -0.03785M -0.00649M -
Change to account receivables -0.35363M -0.44340M -0.07200M 0.27M -0.26346M
Sale purchase of stock - - - - -
Other cashflows from financing activities - 0.28M 0.42M 0.42M 1.62M
Change to netincome - - - - 0.50M
Capital expenditures 2.18M 0.64M 1.99M 2.12M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 1.80M -0.76832M -0.22628M 0.41M -0.93740M
Stock based compensation 1.90M 1.46M 1.52M 3.13M 2.25M
Other non cash items -0.41763M 1.27M -2.51166M -0.90003M -1.84445M
Free cash flow -16.90234M -20.47577M -13.85927M -16.03478M -8.26299M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
PINK
Perimeter Medical Imaging AI Inc
0.03 6.38% 0.50 3.13 - 16.45 7.59 13.18 -2.5521
TLT
Theralase Technologies Inc.
- -% 0.27 - - 79.39 65.46 71.69 -12.0585
CNVI
Conavi Medical Corp.
-0.02 4.76% 0.40 - - 3.45 - 5.24
ASG
Aurora Spine Corp
- -% 0.26 - - 1.28 4.33 1.08 217.56
VPT
VentriPoint Diagnostics Ltd
-0.005 4.35% 0.11 - - 117.51 7.13 130.49 -6.6788

Reports Covered

Stock Research & News

Profile

Perimeter Medical Imaging AI, Inc., a medical technology company, provides advanced imaging solutions to address unmet medical needs. The company offers the Perimeter S-Series optical coherence tomography (OCT) imaging system, which delivers high-resolution margin visualization of excised tissue specimens in the operating room. It is also developing the Perimeter B-Series OCT with ImgAssist artificial intelligence technology for patients undergoing breast conservation surgery. In addition, the company provides a proprietary image library and consumable specimen containers to hospitals and cancer surgery centers. Perimeter Medical Imaging AI, Inc. is headquartered in Toronto, Canada.

Perimeter Medical Imaging AI Inc

555 Richmond Street West, Toronto, ON, Canada, M5V 3B1

Key Executives

Name Title Year Born
Mr. Jeremy Sobotta CEO, Pres & Director NA
Mr. Merle Thomas Boon Chief Operating Officer NA
Mr. Andrew Berkeley Co-Founder & Head of Bus. Devel. NA
Mr. Christopher K. Scott Chief Financial Officer 1970
Mr. Vladimir Pekar Head of AI Algorithm Devel. NA
Ms. Rochelle Keen Head of Clinical Research Programs NA
Mr. Steve Sapot Chief Commercial Officer NA
Mr. Adrian Mendes CEO & Director NA
Mr. Andrew Berkeley Co-Founder & Chief Innovation Officer NA
Ms. Sara Brien Chief Financial Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.